|
PTGX
|
Protagonist Therapeutics, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
PSTX
|
Poseida Therapeutics, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
MRSN
|
Mersana Therapeutics, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
KNSA
|
Kiniksa Pharmaceuticals, Ltd.
|
0.05%
|
US
|
NASDAQ
|
|
IGMS
|
IGM Biosciences, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
GLPG
|
Galapagos NV
|
0.05%
|
US
|
NASDAQ
|
|
CBAY
|
CymaBay Therapeutics Inc.
|
0.05%
|
US
|
NASDAQ
|
|
CARA
|
Cara Therapeutics, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
ARDX
|
Ardelyx, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
AMRN
|
Amarin Corporation plc
|
0.05%
|
US
|
NASDAQ
|
|
ABCM
|
Abcam plc
|
0.05%
|
US
|
NASDAQ
|
|
WVE
|
WAVE Life Sciences Ltd.
|
0.05%
|
US
|
NASDAQ
|
|
ME
|
23andMe Holding Co.
|
0.05%
|
US
|
NASDAQ
|
|
VNDA
|
Vanda Pharmaceuticals Inc.
|
0.04%
|
US
|
NASDAQ
|
|
TSVT
|
2seventy bio, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
STRO
|
Sutro Biopharma, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
SRRK
|
Scholar Rock Holding Corporation
|
0.04%
|
US
|
NASDAQ
|
|
NKTR
|
Nektar Therapeutics
|
0.04%
|
US
|
NASDAQ
|
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
0.04%
|
US
|
NASDAQ
|